Bayer Falls Short in Bid to Beat Eliquis in Afib, But Key Stroke Study Continues

A VPN is an essential component of IT security, whether you’re just starting a business or are already up and running. Most business interactions and transactions happen online and VPN

An independent data monitoring committee concluded Bayer’s experimental drug for atrial fibrillation would not be more effective than Eliquis, a blockbuster product currently used for the indication. Consequently, Bayer decided to stop that Phase 3 test for the once-daily oral small molecule.

Leave a Replay

Sign up for our Newsletter

Contact Us